A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)
INTRODUCTION:: PIONEER (NCT01185314) was a prospective, multinational, epidemiological study of epidermal growth factor receptor (EGFR) mutations in patients from Asia with newly diagnosed advanced lung adenocarcinoma. METHODS:: Eligible patients (aged ≥20 years) had untreated stage IIIB/IV adenocar...
Saved in:
Main Authors: | Shi Y., Au J.S.-K., Thongprasert S., Srinivasan S., Tsai C.-M., Khoa M.T., Heeroma K., Itoh Y., Cornelio G., Yang P.-C. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84893353535&partnerID=40&md5=fccaf78f9ffaa423847d6a5efd7c48c0 http://cmuir.cmu.ac.th/handle/6653943832/1689 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)
by: Yuankai Shi, et al.
Published: (2018) -
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)
by: Yuankai Shi, et al.
Published: (2018) -
The relationship between Epidermal Growth Factor Receptor (EGFR) mutation and computed tomography findings in lung adenocarcinoma
by: Agnes Septiani, et al.
Published: (2019) -
RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status
by: Omar, M.F.M., et al.
Published: (2014) -
Clinical correlations with EGFR circulating tumor DNA testing in all-stage lung adenocarcinoma
by: Incharoen P.
Published: (2023)